Longevity of immunity following COVID-19 vaccination: a comprehensive review of the currently approved vaccines

Longevity of immunity following COVID-19 vaccination: a comprehensive review of the currently approved vaccines

It is unknown how long the immunity following COVID-19 vaccination lasts. The current systematic review provides a perspective on the persistence of various antibodies for available vaccines.Both the BNT162b2 and the mRNA-1273 induce the production of IgA antibodies, reflecting the possible preventi...

Full description

Bibliographic Details
Main Authors:	Elham Jamshidi, Amirhossein Asgary, Paria Shafiekhani, Yasaman Khajeamiri, Kawthar Mohamed, Hadi Esmaily, Sahand Jamal Rahi, Nahal Mansouri
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-11-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	covid-19 vaccines sars-cov-2 immunogenicity humoral immunity cell-mediated immunity antibody persistence long-term protection long-term immunity
Online Access:	http://dx.doi.org/10.1080/21645515.2022.2037384

Similar Items

Persistence of SARS-CoV-2-antibodies against N, S and RBD after natural infection
by: Mitra Jafari, et al.
Published: (2023-11-01)

Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine
by: Pierre Van Damme, et al.
Published: (2017-05-01)

Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge
by: J. Hoes, et al.
Published: (2022-01-01)

Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction
by: Yongji Wang, et al.
Published: (2020-10-01)

Five Year Follow Up of Extremely Low Gestational Age Infants after Timely or Delayed Administration of Routine Vaccinations
by: Ingmar Fortmann, et al.
Published: (2021-05-01)

Evaluation of Long-Term Adaptive Immune Responses Specific to SARS-CoV-2: Effect of Various Vaccination and Omicron Exposure
by: Hyunhye Kang, et al.
Published: (2024-03-01)

Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China
by: Zhen-Zi Wang, et al.
Published: (2017-04-01)

Twenty years of universal vaccination against hepatitis B in Italy: achievements and challanges
by: Luisa Romano', et al.
Published: (2012-04-01)

Persistence of immunity 18–19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy
by: Luisa Romanò, et al.
Published: (2017-05-01)

Long-term follow-up in patients with HIV vaccinated with pandemic influenza A(H1N1)/09 AS03-adjuvanted split virion vaccine and seasonal trivalent influenza split virion vaccine
by: Karlis Pauksens
Published: (2013-08-01)

Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction
by: Xiaoli Wang, et al.
Published: (2023-08-01)

Circular RNA vaccines with long-term lymph node-targeting delivery stability after lyophilization induce potent and persistent immune responses
by: Jiawu Wan, et al.
Published: (2024-01-01)

Assessment of Perceived Barriers to Herpes Zoster Vaccination among Geriatric Primary Care Providers
by: Katherine Montag Schafer, et al.
Published: (2016-10-01)

Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial
by: Innocent Valéa, et al.
Published: (2020-06-01)

Hepatitis A vaccination and its immunological and epidemiological long-term effects – a review of the evidence
by: Christian Herzog, et al.
Published: (2021-05-01)

Low antibody titers five years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees
by: Velumani, Sumathy, et al.
Published: (2016)

Long time persistence of antibodies against Mumps in fully MMR immunized young adults: an Italian retrospective cohort study
by: Francesco Paolo Bianchi, et al.
Published: (2020-11-01)

Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against Mycobacteria
by: Carina Carvalho Dos Santos, et al.
Published: (2020-03-01)

Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations
by: Jennifer Serwanga, et al.
Published: (2024-01-01)

Carbohydrate-Based Adjuvants for Vaccine Production
by: S. S. Kurashova, et al.
Published: (2018-06-01)

Sarm1 deficiency impairs synaptic function and leads to behavioral deficits, which can be ameliorated by an mGluR allosteric modulator
by: Chia-Wen eLin, et al.
Published: (2014-04-01)

Long-term antibody persistence against hepatitis B in adolescents 14–15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy
by: Tino F. Schwarz, et al.
Published: (2019-01-01)

Long-Term Persistence of Antibody Response with Two Doses of Inactivated Hepatitis A Vaccine in Children
by: Ashish Agrawal, et al.
Published: (2020-07-01)

Pattern-Recognition Receptor Agonist-Containing Immunopotentiator CVC1302 Boosts High-Affinity Long-Lasting Humoral Immunity
by: Luping Du, et al.
Published: (2021-11-01)

Development of an Adeno-Associated Virus-Vectored SARS-CoV-2 Vaccine and Its Immunogenicity in Mice
by: Xi Qin, et al.
Published: (2022-03-01)

Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study
by: Francesco Paolo Bianchi, et al.
Published: (2021-05-01)

Pneumococcal Vaccination in Adults: A Narrative Review of Considerations for Individualized Decision-Making
by: Kay Choong See
Published: (2023-04-01)

Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season
by: Yuting Liao, et al.
Published: (2022-11-01)

Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against Leishmania
by: Negar Seyed, et al.
Published: (2018-06-01)

Hepatitis B virus infection seromarkers among college freshmen and their immune responses to different vaccination policies of hepatitis B vaccine
by: Yuyang Xu, et al.
Published: (2021-11-01)

Exposure to medication for neurological disease in pregnancy – time to consider the long-term implications?
by: Chen Liu, et al.
Published: (2023-09-01)

Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection
by: Sophie Novelli, et al.
Published: (2020-12-01)

Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study
by: Ihsan Ates, et al.
Published: (2023-07-01)

Cytotoxic T-Cell-Based Vaccine against SARS-CoV-2: A Hybrid Immunoinformatic Approach
by: Alexandru Tirziu, et al.
Published: (2022-01-01)

Strategically Funny: Romantic Motives Affect Humor Style in Relationship Initiation
by: Theresa E. DiDonato, et al.
Published: (2016-08-01)

REACTOGENITY OF TICK-BORNE ENCEPHALITIS VACCINE ENCEPUR ADULT AND IMMUNE RESPONSE
by: G. N. Leonova, et al.
Published: (2014-07-01)

The durability of vaccine-induced protection: an overview
by: Vipin M. Vashishtha, et al.
Published: (2024-12-01)

Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines – A systematic review
by: Anke L. Stuurman, et al.
Published: (2017-03-01)

Enhanced Immune Responses in Mice Induced by the c-di-GMP Adjuvanted Inactivated Vaccine for Pseudorabies Virus
by: Liting Hou, et al.
Published: (2022-03-01)

A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children
by: Leyla Namazova-Baranova, et al.
Published: (2022-01-01)